Antibiyotikler ve Direnç
Özet
Veteriner hekimlikte antibiyotikler, bakteriyel enfeksiyonların tedavisinde temel ajanlar olup hayvan sağlığı ve üretim verimliliği açısından büyük önem taşımaktadır. Antibiyotikler etkilerini farklı mekanizmalar aracılığıyla göstermektedir. Antibiyotiklerin kullanımında hastalık etkeni, ilacın etki etmesi istenen bölge, uygulanacak hayvan türü ile ilaçların farmakokinetik ve farmakodinamik özellikleri dikkate alınmaktadır. Terapötik, profilaktik ve metafilaktik amaçlarla kullanılan antibiyotiklerin bilinçsiz bir şekilde kullanımı tedavi etkinliğini azaltabilmektedir. Bununla birlikte, antibiyotiklerin bilinçsiz ve uygunsuz kullanımı, yanlış dozlama, yetersiz tedavi süresi ve geniş spektrumlu ajanların gereksiz kullanımı direnç gelişmesine neden olmaktadır. Bu nedenle veteriner antibiyotiklerin akılcı kullanımı, doğru tanı, uygun ilaç seçimi ve düzenleyici kurallara uyum ile sağlanmalı, böylece hem hayvan hem de halk sağlığı korunmalıdır.
In veterinary medicine, antibiotics serve as cornerstone agents in managing bacterial infections, playing a vital role in sustaining both animal health and livestock productivity. These antimicrobials exert their therapeutic effects via distinct biochemical pathways. The clinical deployment of antibiotics necessitates a comprehensive evaluation of the underlying pathogen, the anatomical target site, the target species, and the drug’s specific pharmacokinetic and pharmacodynamic (PK/PD) profiles. Although utilized across therapeutic, prophylactic, and metaphylactic paradigms, the indiscriminate administration of these agents can substantially undermine treatment efficacy. Moreover, improper usa characterized by erroneous dosing protocols, suboptimal treatment durations, and the unwarranted reliance on broad-spectrum drugs drives the proliferation of antimicrobial resistance. Therefore, the rational stewardship of veterinary antibiotics demands precise diagnosis, meticulous drug selection, and strict compliance with regulatory frameworks to effectively safeguard both animal well-being and public health.
Referanslar
Anandabaskar, Nishanthi. "Protein synthesis inhibitors." Introduction to basics of pharmacology and toxicology: volume 2: essentials of systemic pharmacology: from principles to practice. Singapore: Springer Nature Singapore; 2021. 835-868.
Babiker, Ahmed et al. “Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation.” The Lancet. Infectious diseases vol.; 2025; 25 (3): 265-275. doi:10.1016/S1473-3099(24)00507-3
Banik, Bimal Krishna ve Das, Aparna. Beta-Lactams: Classifications, Biogenesis, Physical Characteristics, and Medicinal Activities. Chemistry and Biology of Beta-Lactams, 1. Suudi Arabistan: CRC Press Taylor &Francis Dergileri, 2024.
Carter, Cailean et al. “Trimethoprim: bactericidal or bacteriostatic activity is dependent on bacterial growth conditions.” Journal of medical microbiology vol.; 2026; 75 (3): 10.1099/jmm.0.002129. doi:10.1099/jmm.0.002129
Chambers, Henry F. "General principles of antimicrobial therapy." Goodman Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, USA; 2006: 1095-1111.
Dalhoff, Axel et al. “Redefining penems.” Biochemical pharmacology vol.; 2006; 71 (7): 1085-95. doi:10.1016/j.bcp.2005.12.003
Devi, Shakshi, et al. "ANTIBIOTICS: A COMPREHENSIVE REVIEW."; 2023.
Doğan, A. Veteriner Farmakoloji. Ankara: Eser Basın Yayın Dağıtım Matbaacılık; 2017.
Dumancas, G. G., Koralege, R. H., Mojica, E. R., Murdianti, B. S., & Pham, P. J. (2014). Penicillins.
Frei, Angelo, et al. "Metals to combat antimicrobial resistance." Nature Reviews Chemistry; 2023; 7 (3): 202-224.
Fukuda, Daisuke et al. “Bacterial DNA topoisomerase IV and DNA gyrase inhibitors: history of the quinolones, their clinical usage and potential alternatives for the future.” The Journal of antimicrobial chemotherapy vol.; 2026; 81 (3): dkag054. doi:10.1093/jac/dkag054
Haddad, Mohammed F., et al. "Antibiotic classification, mechanisms, and indications: A review." International Journal of Medical and All Body Health Research; 2024; 5 (3): 39-46.
Hutchings, Matthew I., Andrew W. Truman, and Barrie Wilkinson. "Antibiotics: past, present and future." Current opinion in microbiology; 2019; 51: 72-80.
Ishak, Angela et al. “Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice.” The Journal of antimicrobial chemotherapy vol.; 2025; 80 (1): 1-17. doi:10.1093/jac/dkae380
Ishak, Angela, et al. "Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice." Journal of Antimicrobial Chemotherapy; 2017; 80 (1): 1-17.
Kara, H. Farmakoloji ve Toksikoloji. Ankara: Ankara Üniversitesi Açık ve Uzaktan Eğitim Fakültesi Yayınları; 2025.
Kaya, S. Farmakolojiye Giriş. 193-203. S. Kaya. Ed. Veteriner Farmakoloji. 1’nci cilt, 6’ncı baskı. Ankara: Medisan Yayınevi; 2014
KÜREKCİ, CEMİL. Genetik ve Epigenetik Değişiklikler, Mikrobiyal Adaptasyon ve Değişim Antimikrobiyel Direnç. Yayın Yeri:Akademisyen Kitabevi, Editör: DOĞRUER YUSUF, Basım sayısı:1, Sayfa sayısı:484, ISBN:9786253756277,
Ledger, Elizabeth V K et al. “Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort.” Microbiology (Reading, England) vol.; 2022; 168 (2): 001136. doi:10.1099/mic.0.001136
Lima, Lidia Moreira et al. “β-lactam antibiotics: An overview from a medicinal chemistry perspective.” European journal of medicinal chemistry vol.; 2020; 208: 112829. doi:10.1016/j.ejmech.2020.112829
LiverTox®: İlaç Kaynaklı Karaciğer Hasarı Hakkında Klinik ve Araştırma Bilgileri . Ulusal Diyabet, Sindirim ve Böbrek Hastalıkları Enstitüsü, 2012.
Miller, Elissa Lane. “The penicillins: a review and update.” Journal of midwifery & women's health vol.; 2002; 47 (6): 426-34. doi:10.1016/s1526-9523(02)00330-6
Nagarajan, Deepesh. Antibiotics and Their Mechanisms of Action. Springer Nature Singapore; 2024.
Pankey, George A., and L. D. Sabath. "Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections." Clinical infectious diseases; 2004; 38 (6): 864-870.
Patangia, Dhrati V et al. “Impact of antibiotics on the human microbiome and consequences for host health.” MicrobiologyOpen vol.; 2022; 11 (1): e1260. doi:10.1002/mbo3.1260
Patel, P., et al. "Antibiotics.[Updated 2023 May 26]." StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
Petri, W. A. "Penicillins, cephalosporins, and other β-lactam antibiotics." Goodman and gilman’s the pharmalogical basis of therapeutics. 11st ed. USA: Mc Graw Hill; 2006: 1127-52.
Poirel, Laurent et al. “Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.” Clinical microbiology reviews vol.; 2017; 30 (2): 557-596. doi:10.1128/CMR.00064-16
Rahal Jr, James J., and Michael S. Simberkoff. "Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens." Antimicrobial agents and chemotherapy; 1979; 16 (1): 13-18.
Rossi, Maddalena et al. “Folate production by probiotic bacteria.” Nutrients vol.; 2011; 3 (1): 118-34. doi:10.3390/nu3010118
Saikia, Shyamalima, and Pankaj Chetia. "Antibiotics: from mechanism of action to resistance and beyond." Indian Journal of Microbiology; 2024; 64 (3): 821-845.
Spellberg, Brad, et al. "Static vs. cidal: it’s not complex; it’s simply incorrect." Antimicrobial Agents and Chemotherapy; 2025; 69 (8): e00513-25.
Tang, Kai, and Heng Zhao. “Quinolone Antibiotics: Resistance and Therapy.” Infection and drug resistance vol.; 2023; 16 811-820. doi:10.2147/IDR.S401663
Venkatesan, Meenakshi et al. “Molecular mechanism of plasmid-borne resistance to sulfonamide antibiotics.” Nature communications vol.; 2023; 14 (1) 4031. doi:10.1038/s41467-023-39778-7
Wald-Dickler, Noah, Paul Holtom, and Brad Spellberg. "Busting the myth of “static vs cidal”: a systemic literature review." Clinical infectious diseases; 2018; 66 (9): 1470-1474.
Wanamaker, Boyce P., and Kathy Lockett Massey. Applied pharmacology for veterinary technicians. Elsevier Health Sciences, 2009.
Yazar E, . Kemoterapötikler, in: Veteriner İlaç Rehberi ve Tedavi El Kitabı, Ed: Yazar E, Ankara: Nobel tıp kitabevi; 2019.
